e-learning
resources
Vienna 2012
Tuesday, 04.09.2012
Treatment of lung cancer
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Primary lung cancer treated using radiofrequency ablation – One year outcome data
F. Kamal, J. Beeson, S. Kaul, S. Stirling, S. Mattison, J. Tennant, P. Normahani, P. Dalal (London, United Kingdom)
Source:
Annual Congress 2012 - Treatment of lung cancer
Session:
Treatment of lung cancer
Session type:
Oral Presentation
Number:
3268
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
F. Kamal, J. Beeson, S. Kaul, S. Stirling, S. Mattison, J. Tennant, P. Normahani, P. Dalal (London, United Kingdom). Primary lung cancer treated using radiofrequency ablation – One year outcome data. Eur Respir J 2012; 40: Suppl. 56, 3268
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Lane-hamilton syndrome and CCF: a fatal association
Related content which might interest you:
Evaluation of quality of life in patients with primary and metastatic lung cancer following radiofrequency ablation
Source: Annual Congress 2012 - Screening, diagnosis, staging and treatment strategies for lung cancer
Year: 2012
Primary lung cancer treated using radiofrequency ablation: Two year outcome data
Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series
Year: 2014
Postoperative predicting value of lung function in patients with lung cancer – Fortune-telling or reality? Evaluation after surgical treatment
Source: Annual Congress 2011 - Lung function today and tomorrow II
Year: 2011
Completion pneumonectomy for lung cancer relapse after surgery – what is a real benefit?
Source: Annual Congress 2009 - Current challenges in thoracic surgery
Year: 2009
Primary tracheal tumors – results and late outcome
Source: Annual Congress 2009 - Preoperative functional assessment and surgery for malignant diseases
Year: 2009
Lung function and quality of life after surgical treatment of non-small cell lung cancer – preliminary results
Source: Annual Congress 2009 - Treatment of lung cancer
Year: 2009
Survival outcomes in advance non-small cell lung cancer – A developing country scenario
Source: Annual Congress 2011 - Quality management for lung cancer patients
Year: 2011
Lung metastases from colorectal cancer – Surgery, early and late postoperative results
Source: Annual Congress 2012 - Instructive clinical aspects of thoracic oncology
Year: 2012
Postoperative complications after pneumonectomy in lung cancer patients – Whether lung function can act as a predictor?
Source: Annual Congress 2010 - Diagnostic and therapeutic problems in surgical oncology
Year: 2010
Is there a change in pulmonary function in patients with COPD and primary lung cancer treated with radiofrequency ablation (RFA)?
Source: International Congress 2014 – Advances in diagnosis and therapy of thoracic tumours
Year: 2014
The effect of post operative physical training on activity after curative surgery for non small cell lung cancer (NSCLC) – RCT
Source: Annual Congress 2012 - The best abstracts in pulmonary rehabilitation
Year: 2012
Pulmonary rehabilitation in advanced lung cancer patients during chemotherapy – Preliminary report
Source: Annual Congress 2012 - The best posters in pulmonary rehabilitation and chronic care
Year: 2012
Electromagnetic navigation and endobronchial ultrasound guided brachytherapy of peripheral inoperable lung cancer – long term results at two centres
Source: Annual Congress 2009 - Stents, needles and sedation
Year: 2009
Radiofrequency ablation of lung neoplasms in patients being no candidates for surgery. The impact of the intervention on the pulmonary function
Source: Annual Congress 2011 - Imaging, functional evaluation and staging for lung cancer patients
Year: 2011
Combined ultrasound-guided needle aspiration in restaging of the non-small-cell lung cancer – A three years experience
Source: Annual Congress 2012 - EBUS-TBNA: a never ending story
Year: 2012
Radiofrequency ablation in the treatment of malignant lung tumors
Source: Annual Congress 2011 - Instructive clinical aspects of lung cancer
Year: 2011
Relapse after radical surgery for non-small cell lung cancer 2005-2009 – A retrospective quality management analysis
Source: Annual Congress 2011 - How to improve lung cancer care
Year: 2011
Metastasectomy – Benign aggression for patients with metastatic dissemination of colorectal cancer
Source: Annual Congress 2010 - Diagnostic and therapeutic problems in surgical oncology
Year: 2010
Comparative analysis of the results of surgical treatment for pulmonary metastases from colorectal cancer and metastases from other primary origin
Source: International Congress 2016 – Open problems in thoracic surgery
Year: 2016
Local alternative treatment to surgery [including radio frequency ablation (RFA) and stereotactic body radiation therapy (SBRT)]
Source: International Congress 2014 – Current therapeutic options in stage I non-small cell lung cancer (NSCLC)
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept